Abstract Tumor necrosis factor receptor subfamily 9 (TNFRSF9) plays a potentially important general role in immune function. Tnfrsf9 gene expression has previously been characterized in late pregnant mouse uterus and placenta. However, little is known about its expression in the uterus during the implantation phase of early pregnancy. We have assessed the levels and localization of Tnfrsf9 expression in the mouse uterus and conceptus during implantation. Relative Tnfrsf9 mRNA levels were significantly higher in implantation than in non-implantation site tissue on days 6.5-8.5 of pregnancy. This increase did not depend on the presence of the conceptus, as mRNA levels were not significantly different between pregnant implantation sites and artificially induced deciduomas. Localization by in situ hybridization revealed a subpopulation of endothelial and uterine natural killer cells expressing Tnfrsf9 in the endometrium during implantation. In the developing conceptus, primary trophoblast giant and ectoplacental cells expressed Tnfrsf9 on days 6.5-8.5, followed by expression in the trophoblast giant cell layers surrounding the conceptus on day 9.5 of pregnancy.
Introduction
Mammalian implantation is the process by which the conceptus comes into intimate contact with the maternal blood supply. This process is necessary for the mother adequately to provide nutrients for fetal development and the successful completion of pregnancy. Implantation in mammals is initiated with the attachment of the conceptus to the uterine wall and is complete with the formation of the functional placenta. One of the first maternal changes during implantation in rodents and humans is a dramatic transformation of the endometrial tissue into decidual tissue (Abrahamsohn and Zorn 1993; Gellersen et al. 2007; Mori et al. 1991) . The hallmark of this change is the differentiation of endometrial fibroblasts into decidual cells, commonly referred to as decidualization or decidual cell differentiation. However, other changes during the development of the decidual tissue include alterations of immune cell populations, extracellular matrix composition, and vascular structure. On the side of the conceptus, the hatched blastocyst composed of trophectoderm cells surrounding the inner cell mass and blastocoel comes into initial contact with the endometrium at the initiation of implantation (Cross et al. 1994) . After the onset of implantation, the trophectoderm cells give rise to trophoblast giant cells, ectoplacental cone cells, and spongiotrophoblast cells all of which contribute to the developing placenta (Cross 2000) .
The tumor necrosis factor receptor superfamily member 9 (Tnfrsf9) gene (4-1BB, Cd137, ILA, Ly63) encodes a 30-kDa membrane glycoprotein (TNFRSF9) that belongs to the tumor necrosis factor receptor (TNFR) family. Although originally thought to be expressed only in activated T cells (Pollok et al. 1993) , we now know that many immune cell types can express Tnfrsf9 including: activated natutal killer (NK; Marvel and Walzer 2010) , NKT (Kim et al. 2008) , B (Zhang et al. 2010) , eosinophil (Heinisch et al. 2001) , mast (Nishimoto et al. 2005) , neutrophil (Heinisch et al. 2000) , mature Treg (Williams and Rudensky 2007) , activated monocyte (Sollner et al. 2007) , and dendritic cells (Wilcox et al. 2002) . TNFRSF9 plays roles in many aspects of innate and adaptive immunity, including cancer immunology and autoimmune disease, about which the reader is referred to several recent reviews for further information (Chen 2006; Cheuk et al. 2004; Croft 2003; Myers and Vella 2005; Nam et al. 2005; Vinay et al. 2006) . Notably, Tnfrsf9 expression can also occur in non-immune cell types such as endothelial (Drenkard et al. 2007) , neuron, astrocyte, and microglia (Reali et al. 2003) cells. However, to the best of our knowledge, the function of this expression is presently not known.
Immunological aspects of embryo implantation have been studied in detail, especially since Sir Peter Medawar originated several exciting hypotheses almost 60 years ago as to why the maternal immune system does not reject the semi-allogenic conceptus during implantation and pregnancy (Medawar 1953) . However, all subsequent work has revealed that these hypotheses and others generated in the interim are insufficient, and thus that more research is necessary (Robertson 2010; Yoshinaga 2008) . In this regard, although TNFRSF9 seems to play many roles in the immune system, little is known about Tnfrsf9 expression at implantation sites in the uteri of pregnant mammals. Recently, Tnfrsf9 expression in the late mouse uterus and placenta has been partially characterized (Zhao et al. 2007) . However, to the best of our knowledge, little is known about the expression of this gene in the uterus or conceptus during the implantation phase of early pregnancy. Since TNFRSF9 is known to play a potentially important role in immunity in general, the purpose of this study has been to determine whether and where Tnfrsf9 is expressed in the mouse uterus and conceptus during implantation in mice.
Materials and methods
Animals CD1 mice purchased from Charles River (Wilmington, Mass., USA) and Il15 knockout mice (Germantown, N.Y., USA) were used. The Il15 knockout mice in a C57BL/6 background were backcrossed to mice of the CD1 strain for over 15 generations, and the generations thereafter were examined in the present study.
CD1 female mice (8-12 weeks old) were mated to CD1 male mice. In some cases, Il15-knockout and wild-type female mice were mated to wild-type and Il15-knockout males, respectively; this generated pregnant mice with conceptuses of all the same (heterozygous) genotype regardless of the maternal genotype. For all mice, the morning that a vaginal plug was discovered was taken as day 0.5 of pregnancy. Mice were killed on day 3.5 (just prior to the onset of implantation) or days 4.5-9.5 after the onset of implantation. Uterine tissues were collected from nonimplantation (NIS) and implantation (IS) segments of the uterus as previously described (Bany and Schultz 2001) . For some experiments, we used a bead-induced decidualization model as described elsewhere (Herington and Bany 2007; Herington et al. 2009 ). Briefly, female mice were mated with vasectomized male mice, and the morning that a vaginal plug was found was considered as day 0.5 of pseudopregnancy. Small beads were then transferred into the uteri of day-2.5 pseudopregnant mice resulting in the formation of deciduoma-containing segments of the uterus. In a similar fashion to uteri of pregnant mice, non-stimulated (NS) and bead-induced deciduoma (BID) segments of the uteri were collected from days 3.5 to 9.5 of pseudopregnancy.
Tissue collection and processing For total RNA isolation, tissues were collected and homogenized in Trizol Reagent (InVitrogen, Carlsbad, Calif., USA). For IS tissues, conceptuses were separated by using fine forceps prior to homogenization. For in situ hybridization, the tissues were fixed overnight in 4% paraformaldehyde and then dehydrated, cleared in xylene, and blocked in paraffin by using standard techniques. Paraffin tissue sections (5 μm) were prepared and mounted onto Superfrost Plus slides (VWR, Radnar, Pa., USA).
Reverse transcription with the polymerase chain reaction RNA isolation followed by quantitative reverse transcription with the polymerase chain reaction (qRT-PCR) was used to measure the relative steady-state levels of Tnfrsf9 mRNA normalized to the housekeeping target 18S rRNA. The approach and precise method used for qRT-PCR has been described in detail previously (Herington et al. 2009 ). The 18S rRNA oligonucleotide primers (5′-CGGCTACCACATCCAAGGAA-3′ and 5′-GCTGGAAT-TACCGCGGCT-3′) were designed based on Genbank accession no. NR_003278, and the annealing temperature used was 61.8°C to obtain the relevant 187-bp amplicon. The Tnfrsf9 oligonucleotide primers (5′-TTGGGAACATT-TAATGACCAGA-3′ and 5′-TCCCGGTCTTAAGCACA-GAC-3′) were designed based on Genebank accession no. NM_011612, and the annealing temperature used was 62°C. The 91-bp amplicon for Tnfrsf9 qRT-PCR was common for both splice variants.
Non-quantitative RT-PCR was used to assess the presence of each of the two splice variants encoding the transmembrane and soluble forms of Tnfrsf9 mRNA. The primers used were as previously described (Shao et al. 2005 ) and produced 771-bp and 636-bp amplicons from the alternatively spliced transmembrane and secreted forms of Tnfrsf9, respectively. RT-PCR was carried out with Superscript II reverse transcriptase (Promega, Madison, Wis., USA) and TopTaq PCR master mix (Qiagen, Valencia, Calif., USA) following the procedures recommended by the manufacturers. PCR was carried out by using an Eppendorf Mastercycler thermocycler (Fisher Scientific, Pittsburgh, Pa., USA) programmed for 36 cycles of 94°C melting, 58°C annealing, and 72°C extension steps for 15, 45, and 20 s, respectively. After a final incubation for 7 min at 72°C, the samples were subjected to agarose gel electrophoresis in the presence of ethidium bromide. The resultant gels were imaged by using a UV trans-illuminator and a Kodak EDAS290 Gel Documentation system (Fisher Scientific).
In situ hybridization Tnfrsf9 mRNA was localized in the tissue sections by using colorimetric in situ hybridization. An amplicon was generated with Tnfrsf9-specific primers 5′-AGGTGGACAGCCGAACTGTAACAT-3′ and 5′-TTCTTCTTCCTGTGGACATCGGCA-3′ by RT-PCR as described above. The resulting amplicon was then cloned into the PGEM-T Easy vector as recommended by the manufacturer (Promega). The sequence and orientation of the clone were verified by sequencing with T7 and SP6 promoter primers (UIUC DNA Sequencing Center). Linear templates were prepared by using the appropriate restriction enzymes, and sense and antisense digoxigenin (DIG)-labeled riboprobes were generated as previously described (Bany and Cross 2006) . In situ hybridization was carried out as described previously (Simmons et al. 2008) , except that the final color development with the 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium substrate was carried out in the presence of 5% polyvinyl alcohol (De Block and Debrouwer 1993) . Slides were counterstained with nuclear fast red. The resulting slides stained purple for Tnfrsf9 mRNA with light red nuclei. Use of sense probes revealed no hybridization signals in any of the tissue types examined (data not shown).
Dolichos biflorus agglutinin lectin histochemistry
In some experiments, after completing the in situ hybridization and color development for Tnfrsf9 mRNA localization, the sections were subjected to three 10-min washes in phosphate-buffered saline (PBS) and stained for Dolichos biflorus agglutinin (DBA) lectin binding. DBA lectin staining was carried out exactly as described previously (Herington and Bany 2007) . Finally, the slides were counterstained with nuclear fast red prior to mounting with cover slips. The resulting slides stained purple for Tnfrsf9 mRNA, brown for DBA lectin, and red for nuclei.
Statistical analysis The effects of day and tissue-type on relative Tnfrsf9 mRNA levels between NIS and IS tissues on days 4.5-8.5 of pregnancy were determined by repeatedmeasures analysis of variance. Differences between means were determined by a t-test and Duncan's multiple range test. The effects of day and tissue-type on relative Tnfrsf9 mRNA between pregnant and pseudopregnant uteri on days 3.5-8.5 were determined by a two-way analysis of variance. Differences between days for BID and IS tissue were determined by using Duncan's multiple range test. Statistical analysis was carried out by using Excel (Microsoft, Redmond, Wash., USA) and Sigmastat (Systat, San Jose, Calif., USA) software.
Results
Tnfrsf9 mRNA levels increase in the uterus during decidualization Relative Tnfrsf9 mRNA levels were determined in the uteri of pregnant mice on days 3.5-8.5 of pregnancy by using qRT-PCR (Fig. 1a) . Tnfrsf9 mRNA levels were low on day 3.5 of pregnancy, just prior to the onset of implantation. After the onset of implantation, mRNA levels in NIS tissues were significantly (P<0.01) increased only on day 5.5, but not days 4.5 plus 6.5-8.5, compared with that of day 3.5 pre-implantation tissue. On the other hand, Tnfrsf9 mRNA levels in IS tissues were significantly (P<0.02) increased on days 4.5-8.5 compared with that of day 3.5 pre-implantation tissue. Finally, mRNA levels between NIS and IS tissues were significantly greater only on days 6.5 (P<0.02), 7.5 (P<0.0005), and 8.5 (P<0.005). The differences between post-implantation samples are depicted by letters over the bars in Fig. 1a . To determine whether the expression of Tnfrsf9 in uterine tissue during decidualization required the presence of a conceptus, we utilized a bead-induced deciduoma model described previously (Herington and Bany 2007; Herington et al. 2009 ). A comparison of mRNA levels between the tissue-types on each given day did not reveal a significant (P<0.05) difference in Tnfrsf9 mRNA levels (Fig. 1b) . Tnfrsf9 mRNA levels were detected at low levels in day-3.5 pseudopregnant and pregnant tissues. After the onset of decidualization, mRNA levels significantly (P<0.001) increased but in a similar fashion in both BID and IS tissues as revealed by a lack of interaction (P>0.05) between the effects of day and tissue-type. The differences between days within BID and IS tissues are depicted by letters over the bars in Fig. 1b . Notably, the primers used for the qRT-PCR above were designed to produce the same 91-bp amplicon, regardless of the splice form from which it was amplified. Therefore, the quantitative signals measured did not discern between splice variants. To determine which splice variants were expressed in the uteri of pregnant mice, we utilized a previously developed RT-PCR strategy (Shao et al. 2008) . As shown in Fig. 1c , both the 771-bp and 636-bp splice variants encoding the membrane and soluble forms of TNFRSF9 were readily detected in the IS tissues on days 5.5-8.5. Similar findings were found for that of day-7.5 BID tissue (Fig. 1c, lane D) . Finally, control samples in which RNA was subjected to RT conditions in the absence of reverse transcriptase followed by PCR showed no amplicons (Fig. 1c, lane -RT) .
Localization of Tnfrsf9 mRNA in uterus during decidualization In situ hybridization was used to localize mRNA in the uterus during implantation on days 5.5-9.5 of pregnancy (Fig. 2) . Tnfrsf9 mRNA hybridization signals were not detected in day-3.5 and day-4.5 tissue (data not shown), nor in NIS tissue on days 5.5-8.5 (Fig. 2a, f, k, p) . However, in IS tissue on day 5.5 ( Fig. 2b) , strong hybridization signals in a small number of large cells in the endometrium were found both in the antimesometrial region just adjacent to the conceptus (Fig. 2c ) and in the mesometrial region (Fig. 2d) . Strong hybridization signals were also detected in vascular endothelial cells near the luminal epithelium at the mesometrial-antimesometrial region boundary (Fig. 2e) . In IS tissues from the uteri of day-6.5 (Fig. 2g-j) and day-7.5 ( Fig. 2l-o) pregnant mice, hybridization signals were seen in similar scattered large cells of the endometrium, but the numbers of these cells dramatically increased. Hybridization signals were also seen in endothelial cells in a similar region found in day-5.5 IS tissue Fig. 2j, o) . Unlike on all other days examined, the number of endothelial cells staining positively on day 7.5 appeared to be greater. One notable difference in the localization of signals in day-6.5 and day-7.5 IS tissues compared with that of day 5.5 was Fig. 1 Quantitative reverse transcription with the polymerase chain reaction (qRT-PCR) and RT-PCR analysis of steady-state Tnfrsf9 mRNA levels and presence of alternatively spliced forms of Tnfrsf9 in the mouse uterus during implantation and decidualization. a qRT-PCR analysis of relative mRNA levels (mean±SEM, n=4) in nonimplantation site (NIS) compared with implantation site (IS) tissue segments on days 3.5-8.5 of pregnancy. Bars bearing similar letters are not significantly different. b qRT-PCR analysis of relative mRNA levels (mean±SEM, n=4) in bead-induced deciduoma (BID) compared to implantation site (IS) tissue segments on days 3.5-8.5 of pseudopregnancy and pregnancy, respectively. c RT-PCR analysis of Tnfrsf9 splice variant expression in non-implantation site (NIS) compared with implantation site (IS) tissue segments on days 5.5-8.5 of pregnancy and day 7.5 BID deciduoma tissue. RT-PCR results are representative of several (n=3) independent samples (DOP day of pregnancy, bp base pair, D deciduoma, -RT control with no reverse transcriptase) Fig. 2 Localization of Tnfrsf9 mRNA in non-implantation (NIS) and implantation (IS) tissue segments of mouse uterine tissue from pregnant mice at days 5-5-9.5 (lettered boxes are shown at higher magnification in corresponding panels). a-x Photomicrographs showing tissues from day-5.5 NIS (a) or IS (b-e), day-6.5 NIS (f) or IS (g-j), day-7.5 NIS (k) or IS (l-o), day-8.5 NIS (p) or IS (q-t), and day 9.5 IS (u-x). These are representative of at least three independent samples. Global linear adjustments of the brightness and color level were made on the photomicrographs to ensure that they more accurately represented the sections as seen under the microscope. Numbers above bars are in microns (AMD antimesometrial decidua, E embryo, EPC ectoplacental cone, MD mesometrial decidua, MLap mesometrial lymphoid aggregate of pregnancy, Plac developing placenta, TGC trophoblast giant cells, V vascular endothelium) b the consistent staining of primary trophoblast giant cells on day 6.5 ( Fig. 2h ) and in the outer ectoplacental cone (EPC) cells on day 7.5 ( Fig. 2m) . Localization of Tnfrsf9 mRNA throughout the EPC was then seen in IS tissue from day-8.5 uteri (Fig. 2q, r) . Further, hybridization signals were detected in a greater number of large cells scattered in the mesometrial decidua and to a lesser extent in cells in the mesometrial lymphoid aggregate of pregnancy (MLap) region, which had started to form (Fig. 2q, s) . Notably, although hybridization signal was seen in some endothelial cells in the antimesometrial decidua close to the conceptus (Fig. 2t) , the signals were weak compared with previous days. Finally, hybridization signals at mid-pregnancy in IS tissue on day 9.5 ( Fig. 2u) were seen in virtually all trophoblast giant cells adjacent to the decidua capsularis (Fig. 2v) and throughout the trophoblast giant cell layer of the late developing placenta adjacent to the mesometrial decidua (Fig. 2w, x) . In a similar fashion to that of day 8.5, scattered cells in the mesometrial decidua of day-9.5 uteri showed strong hybridization signals. However, the numbers of these cells appeared to be more numerous in the MLap region (Fig. 2u) .
Uterine Tnfrsf9 expression in Il15-knockout mice Previous work has shown that the majority of immune cells within the endometrium during implantation are uterine natural killer (uNK) cells. We had earlier evaluated the numbers and localization of DBA-lectin-positive uNK cells in IS tissues in the mouse uterus during implantation (Herington and Bany 2007) . Since the pattern of localization for Tnfrsf9 mRNA seen in the scattered cells of the endometrium in this study looked similar to that for the localization of uNK cells, we assessed Tnfrsf9 mRNA levels and localization in the uteri of Il15-deficient (knockout) mice. These mice lacked uNK cells (Barber and Pollard 2003) . As shown in Fig. 3a , steady-state mRNA levels were dramatically and significantly greater in IS tissues from the uteri of wild-type compared with Il15-knockout mice on days 4.5, 5.5, 6.5, 7.5, and 8.5 of pregnancy.
Next, we assessed the presence of Tnfrsf9 mRNA splice variants in the wild-type compared with Il15-knockout mice (Fig. 3b) . Both the 771-bp and 636-bp splice variants were readily detected in the IS tissues of pregnant wild-type mice at days 5.5-8.5. Similar findings were observed for the IS tissues from Il15-knockout mice with the noted exception that we did not consistently see the two amplicons in day-5.5 samples. We also assessed the presence of splice variants in samples of the developing placenta/conceptus of wild-type pregnant mice at days 7.5-9.5 (Fig. 3b) . Both the 771-bp and 636-bp splice variants of Tnfrsf9 were readily detected in these tissues.
To determine whether the scattered cells found in the mesometrial decidua were immune cells, we compared Tnfrsf9 mRNA localization in wild-type verses Il15-knockout mice in IS tissue of day-7.5 pregnant mice. Hybridization signals for Tnfrsf9 mRNA were seen in the scattered cells of the mesometrial decidua in IS tissues from the uteri of day-7.5 pregnant wild-type mice (Fig. 4a) . These hybridization signals were not seen in IS tissue from Il15-knockout mice (Fig. 4b) . On the other hand, hybridization signals remained positive for the contents mainly in endothelial cells in the decidua of Il15-knockout mice (Fig. 4c) . The qRT-PCR and in situ localization results strongly suggested that a significant amount of Tnfrsf9 expression in the mouse uterus during implantation came from uNK cells. Therefore, we also carried out double-staining with a combination of in situ hybridization for Tnfrsf9 mRNA and DBA lectin histochemistry for uNK cells. Most, but not all, Tnfrsf9-positive cells also stained positively for DBA lectin (Fig. 4d, e) on day 7.5 of pregnancy. The potential identity of the Tnfrsf9-positive but DBA lectin-negative cells was not pursued further. Fig. 3 qRT-PCR and RT-PCR analysis of steady-state mRNA levels and presence of alternatively spliced mRNA forms of Tnfrsf9 in implantation site tissue segments of pregnant wild-type (WT) and Il15-knockout (KO) mice. a qRT-PCR analysis of relative mRNA levels of Tnfrsf9 mRNA in WT compared with KO IS tissue segments on days 3.5-8.5 of pregnancy (asterisks significant difference in mRNA levels on a given day of pregnancy between samples from WT and KO mice: *P<0.05, **P<0.005, ***P<0.0005). b RT-PCR analysis of Tnfrsf9 splice variant expression in implantation site tissue segments from the uteri of wildtype (WT) and Il15-knockout (KO) mice on days 5.5-8.5 of pregnancy and in conceptus tissues of WT mice (C) from days 7.5-9.5. RT-PCR results are representative of several (n=3) independent samples (bp base pair, DOP day of pregnancy, -RT control with no reverse transcriptase) Fig. 4 Localization of Tnfrsf9 mRNA and cells positive for DBA lectin binding in implantation (IS) tissue segments of pregnant uteri (lettered boxes are shown at higher magnification in corresponding panels). a-e Photomicrographs showing day-7.5 IS tissue in wild-type (a, d, e) and Il15-knockout (b, c) mice. d, e Double-staining for Tnfrsf9 mRNA and DBA lectin. f-i Photomicrographs showing day-9.5 IS tissue in Il15-knockout mice. These are representative of at least three independent samples. Global linear adjustments of the brightness and color level were made on the photomicrographs to ensure a more accurate representation of the sections as seen under the microscope. Numbers above bars are in microns (EPC ectoplacental cone, TGC trophoblast giant cells, V vascular endothelium) However, they might have been the subpopulation of DBAnegative but periodic-acid/Schiff-positive uNK cells previously shown to be in the endometrium at this time (Zhang et al. 2009 ). On the side of the conceptus, we noted that ectoplacental cells of heterozygous Il15 conceptuses in the uteri of day-7.5 pregnant Il15-knockout mice did not consistently stain positively for Tnfrsf9 mRNA. This was in contrast to conceptuses of the same genotype in the uteri of wild-type mice (Fig. 4a-c) . Finally, Tnfrsf9 mRNA was localized in IS tissue of day-9.5 pregnant Il15-knockout mice (Fig. 4f-i) . Little hybridization signal was detected in the day-9.5 decidua basalis and MLap, whereas strong localization signals were seen in the trophoblast giant cells surrounding the conceptus.
Discussion
The Tnfrsf9 gene is believed to play key roles in several aspects of immunity (Croft 2003; Gellersen et al. 2007; Heinisch et al. 2000 Heinisch et al. , 2001 Kim et al. 2008; Marvel and Walzer 2010; Michel and Schwarz 2000; Myers and Vella 2005; Nishimoto et al. 2005; Pollok et al. 1993; Salih et al. 2002; Vinay et al. 2006; Zhang et al. 2010 ), but little is known about its function, if any, in the immunology of early pregnancy. Recently, Zhao et al. (2007) have shown that Tnfrsf9 mRNA can be detected in the implantation sites of pregnant mice, and that levels decrease between days 13.5 and 18 of pregnancy. The present study extends this work and demonstrates that Tnfrsf9 expression dramatically increases in implantation sites of the uterus during the implantation phase of pregnancy. Localization of this expression has revealed that the major cell types of the uterus that express Tnfrsf9 are a subset of endothelial and uNK cells in the mesometrial decidua. Alternatively, expression in the conceptus has been localized to trophoblast giant and ectoplacental cone cells. These results suggest that Tnfrsf9 expression plays a crucial immunerelated part in mouse implantation, although its precise function needs to be further evaluated.
Previous experiments have shown that mouse trophoblast cells express Tnfrsf9 in vitro, and that expression levels increase in response to interferon gamma (IFNG) treatment (Hoshida et al. 2007 ). Croy et al. (2002) have estimated that, in vivo, uNK cells provide about 90% of the IFNG on the mesometrial side of the implantation site in mice. Therefore, we are tempted to speculate that IFNG from uNK cells drives the expression of Tnfrsf9 in the trophoblast cells shown in the present study. Indeed, the reduced/lack of Tnfrsf9 expression in trophoblast cells of day-7.5 conceptuses in the uteri of Il15-knockout mice (lacking uNK cells) supports this conjecture. However, the possibility that the development of trophoblast cells and, thus, of the placenta is delayed in the Il15-knockout mice also cannot be ruled out at present.
The specific ligand of TNFRSF9 is normally expressed on antigen-presenting cells and is called the tumor necrosis factor subfamily 9 ligand (TNFSF9; for reviews, see Salih et al. 2002; Schwarz 2005; Schwarz 2006; Shao and Schwarz 2011) . TNFSF9, encoded by the Tnfsf9 gene, is a transmembrane glycoprotein of the tumor necrosis factor (TNF) family of proteins and is found mainly on the surface of antigenpresenting cells. Upon binding, TNFSF9 activates membrane TNFRSF9 and initiates a complex set of intracellular signaling pathways (Lee and Kwon 2006) ; TNFRSF9 also provides a reverse signal upon binding and initiates intracellular signaling pathways in the TNFSF9-expressing cells (Schwarz 2006; Shao and Schwarz 2011) . Therefore, like other members of the TNF superfamily of receptors and ligands (Eissner et al. 2004) , membrane TNFRSF9-TNFSF9 signaling is bidirectional. With the major finding of this study being that Tnfrsf9 is expressed in the conceptus and endometrium during implantation, further work is warranted to determine whether Tnfsf9 is expressed in the uterus or conceptus during implantation.
Two forms of TNFRSF9 exist because of alternative splicing of the Tnfrsf9 transcript (Michel and Schwarz 2000) , but little is known regarding their function. One form is the fully functional transmembrane protein, whereas the other is soluble, lacks a transmembrane domain, and is secreted by the cells. Since soluble TNFRSF9 is secreted, it might act in an autocrine, paracrine, or endocrine fashion. Although little is known about the functions of soluble TNFRSF9, it is commonly believed to be immunosuppressive by acting as a competitive antagonist of membrane TNFRSF9 and by binding to, but not activating, TNFSF9 signaling (Schwarz 2006) . In the present study, we have found that both splice forms are expressed in the maternal and conceptus tissues during implantation. We speculate that the production of soluble TNFRSF9 might be involved, at least in part, in the immunosuppressive activities that suppress the rejection of the conceptus by the maternal immune system. This could occur at the level of the uterus or perhaps of the lymphoid organs, which are also believed to play an important role in immune tolerance to the conceptus (Taglauer et al. 2010) . Indeed, the blockade of TNFRSF9-TNFSF9 interactions increases allograft survival in cardiac transplants (Cho et al. 2004; Saiki et al. 2008) . However, such an immunosuppressive role for secreted TNFRSF9 by the uterus or trophoblast to obtain maternal immune tolerance to the conceptus is currently pure conjecture. Clearly, more work is required to understand the potential roles of membrane verses soluble Tnfrsf9 expression in the mouse uterus and conceptus during pregnancy. Enthusiasm to conduct such work might however be reduced, since Tnfrsf9-knockout mice have been noted to be completely fertile (Kwon et al. 2002) . However, to the best of our knowledge, data concerning detailed assessments of the fertility and pregnancies of these animals cannot be found in the literature. Further, removal of the expression of a Tnfrsf9 in the entire mouse may be immunosuppressive itself, and so alternate strategies might be needed to study its function in maternal immune tolerance to the conceptus.
TNFRSF9 is believed to be important in cancer biology and in some autoimmune diseases; this has provided interest in developing TNFRSF9 immunotherapies (Cheuk et al. 2004; Kim and Broxmeyer 2001; Nam et al. 2005; Shao et al. 2008; Sun et al. 2003) . The determination of the role of Tnfrsf9 expression in implantation biology and pregnancy is crucial for ascertaining potential harmful or helpful effects that such therapy might have on pregnant patients or on those trying to become pregnant. Further, knowledge about TNFRSF9 signaling in pregnancy might help new approaches to be devised for the treatment of some forms of immune-related infertility in females.
